The Hard Questions
A framework that cannot survive honest critique cannot survive deployment. Before the first board review, the CMO should be able to answer six questions from their own team. These are not the questions a sceptical outsider would ask — those tend to be superficial. These are the questions a thoughtful insider would ask after running the diagnostic for thirty days.
Question 1 — Is the 10–15% NeoMarketing rung real, or asserted? The honest answer is that it is provisional. The Tax Ladder is empirically observable: CRM costs 5–10%, Adtech costs 20–25%, and the gap between them is real. The claim that NeoMarketing — Atrium, Meridian, NeoNet, ActionAds — can occupy that gap at 10–15% effective tax is theoretical. It depends on a stack of assumptions: that ActionAds can fund the NeoMail rhythm, that Atrium can restore attention at meaningful rates, that NeoNet can replace platform tax with cooperative surplus. None of those has been demonstrated at scale in production by an independent brand outside of vendor pilots. The diagnostic half of AOS holds regardless — the Tax Ladder, TAT, Seven Buckets, and Dashboard are useful for diagnosis even if NeoMarketing economics fail. The CMO should treat NeoMarketing as a prescription under test, not as proven infrastructure.
Question 2 — Can attention recency be measured cleanly? Not exactly. Different teams will draw different lines on what counts as a meaningful attention event — an email open with image disabled, a push notification dismissed, an app open of three seconds — each is a judgement call. The problem is procedural, not analytical. Pick a definition, document it, lock it for a quarter, refine afterwards. The inconsistency cost of changing the definition mid-quarter is higher than the precision cost of picking an imperfect definition.
Question 3 — Do the Seven Plays sequence equally? No. Some require new product (Plays 5 and 7 lean on NeoMails and ActionAds, which most brands do not have). Some run on existing stack (Play 6 needs nothing but a suppression rule and a redirected budget). The framework lists them as a system; in practice, the CMO sequences them by deployment readiness. Deploy the readily-deployable plays in quarter one; let their data inform what to build for quarter two. A brand that tries to deploy all seven simultaneously is running a project, not a pilot.
Question 4 — How is the Beta baseline really set? The same problem hedge funds have with benchmark selection. There is no neutral answer. Use last-year-same-period as Beta v1 — imperfect, but defensible. Refine through incrementality testing in subsequent quarters: holdout cohorts, geo splits, time-shifted controls. The discipline is not in finding a perfect baseline; it is in measuring against something rather than against zero. A weak baseline rigorously applied beats a strong baseline negotiated quarterly.
Question 5 — Doesn’t AOS risk becoming consulting jargon? Yes. Names travel faster than disciplines. There will be brands that talk AOS — putting the word on slides, using “Alpha Generated” loosely, naming their dashboards “AOS Dashboard” — without running the diagnostic, picking the plays, or installing the governance. The dashboard is the test. If a brand cannot produce the ten metrics on a Monday morning, it does not run AOS regardless of what its slides say.
Question 6 — Does the CMO actually have the authority to run AOS? Probably not, on day one. AOS assumes cross-functional reach: CRM operations, marketplace identity capture, pricing and promotion policy, agency contracts. In most D2C brands, the CMO owns some of these and influences others. The diagnostic itself is the case for the missing authority. When the CMO walks into the CEO’s office with the Paid Repeat Leakage number, the Weakening Pool count, and the R1 Recoverable Value, the case for cross-functional governance writes itself. AOS is not a marketing initiative that needs CMO authority; it is a customer-economics programme that produces the case for the authority.
These six questions are not objections to be deflected. A CMO who can answer them — including the honest concession that NeoMarketing economics are unproven — earns more trust from a sceptical board than one who pretends the framework has no weak points.
